Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q4 2022 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$28.83M$28.83Mderived+8.7% vs Q4 2021 Net Income$107.00K$107.00Kderived−72.4% vs Q4 2021 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$14,073,000+3.1% Operating Incomederived$1,029,000−35.8% Operating Cash Flowderived$4,566,000+23.0% Free Cash Flowderived$4,155,000+24.5% Margins · derivedGross margin48.8%−2.7 pt vs Q4 2021
Operating margin3.6%−2.5 pt vs Q4 2021
Net margin0.4%−1.1 pt vs Q4 2021
ended Dec 31, 2022 · filed Mar 16, 2023 · 75 d after period end